APR 11, 2018 09:00 AM PDT

Genomic profiling in Community Practice: Ensuring the Right Test for the Right Patient Every Time

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Vice President and Chief Medical Officer, Genomic and Clinical Pathology Services, PathGroup
    Biography
      Dr. Chandra, is currently the Chief Medical Officer of Genomic and Clinical Pathology Services at PathGroup. Dr. Chandra holds board certifications in anatomic and clinical pathology, hematopathology and molecular genetic pathology. He completed his AP/CP training and fellowships in hematopathology, oncologic pathology and molecular pathology at NYU Langone Medical Center and the University of Texas-MD Anderson Cancer Center. While at MD Anderson, he served as Chief Fellow and received numerous awards for his research on translocation t(9;11) associated acute myeloid leukemia. Dr. Chandra joined PathGroup in 2011 as Associate Medical Director of Molecular Pathology and became Director in March of 2013. He has presented numerous abstracts and platform presentations at various pathology meetings, published articles in peer-reviewed journals and composed a book chapter on cutaneous T-cell lymphomas. Dr. Chandra is a member of the American Society of Clinical Pathology, Association of Molecular Pathology where he also serves on the Economic Affairs Committee and Clinical Practice Committee. Dr. Chandra also serves on the Personalized Healthcare Committee through the College of American Pathologists. Dr. Chandra is a medical consultant in molecular pathology and personalized medicine and is considered a national thought leader in Precision Oncology and Cancer Genomics.

    Abstract:

    Genomic profiling in various cancers has become standard of care today.  Dr. Chandra will discuss the challenges and opportunities of precision oncology testing in community practice and will highlight key learning objectives through case studies.  


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUN 26, 2019 09:00 AM PDT
    C.E. CREDITS
    JUN 26, 2019 09:00 AM PDT
    DATE: June 26, 2019TIME: 9:00am PDT, 12:00pm EDT An excessive number of software solutions are available to help manage your clinical, biobank, or biorepository sample inform...
    JUL 31, 2019 09:00 AM PDT
    C.E. CREDITS
    JUL 31, 2019 09:00 AM PDT
    DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...
    AUG 15, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 15, 2019 09:00 AM PDT
    DATE: August 15, 2019TIME: 9:00am PDT, 12:00pm EDT Radiation therapy is a critical tool for the treatment of brain tumors, however, exposure to high doses of ionizing radiation...
    Loading Comments...
    Show Resources